Coapt

Chicago, IL, USA  All United States companies → Founded 2012
Medical Device / Hardware Specialty-Focused AI
Orthopedics Physical Medicine & Rehab Plastic Surgery
Neurology AI Surgical AI Wearables & Remote Monitoring (RPM)
Acquired (by Hanger, expected Q1 2025); previously received federal grants and debt funding — Over $2.45 million (including a $2.3M DoD grant and $150K PPP loan); total funding not fully disclosed

Products

COMPLETE CONTROL System Gen2
Coapt
Neurology AI
Coapt's COMPLETE CONTROL System Gen2 uses AI and machine learning for intuitive, natural control of upper-limb prosthetics, enhancing functionality for individuals with limb loss or difference.
Alpha Control Liner System (ACLS)
Coapt
Neurology AI
The Alpha Control Liner System (ACLS) by Coapt is an FDA-cleared prosthetic interface solution with integrated electrodes, enhancing control, comfort, and ease of use for upper extremity prosthesis wearers by providing consistent myoelectric signal capture for advanced pattern recognition systems.

See all 2 products →

About Coapt

Coapt, LLC is a pioneering healthcare AI company specializing in advanced human-machine interface technologies for upper limb prostheses. Their flagship product, the Complete Control System Gen2, leverages sophisticated machine learning and artificial intelligence algorithms to decode natural muscle signal patterns, enabling intuitive and personalized control of prosthetic hands, wrists, and elbows. This system is designed to integrate seamlessly with a wide array of existing prosthetic components, offering users enhanced independence and a more natural interaction with their bionic limbs.

Beyond prosthetic control, Coapt is actively engaged in research and development of virtual reality (VR) and hardware-based therapies. Notably, they received a significant grant from the Department of Defense to develop VR-based solutions aimed at easing phantom limb pain for amputees. This innovative approach combines myoelectric signal detection with immersive VR environments, demonstrating potential for both improved prosthesis control and effective, engaging pain management. The company’s commitment to clinically dedicated engineering and continuous innovation aims to improve the quality of life for prosthesis users.

Focus Areas

Human-machine interface Myoelectric pattern recognition Upper-limb prosthetics AI for prosthetic control Machine learning Bionics Rehabilitation Phantom limb pain therapy

Business Intelligence

Key InvestorsUnited States Department of Defense (grants)
PartnershipsWillowWood Global LLC (Alpha Control Liner System), Hanger, Inc. (impending acquisition)
AcquisitionsLiberating Technologies, Inc. (July 2021)
TechnologyComplete Control Gen2 system, Myoelectric pattern recognition, Machine learning, Artificial intelligence (AI operating system, Control Coach AI companion, Control Companion mobile app for iOS and Android)
FDA Clearances3 cleared products (estimated)

What Physicians Need to Know

Human-Machine Interface & Myoelectric Pattern Recognition
Coapt specializes in advanced myoelectric pattern recognition technology, specifically their 'Complete Control Gen2' system, which decodes natural muscle signals from the residual limb into intuitive and proportional prosthetic movements. This allows for more natural and seamless control of upper-limb prostheses.
Upper-Limb Prosthetics & Bionics
Their core product, the Complete Control Gen2 system, acts as an intent decoder module for powered upper-limb prostheses, enabling users to command prosthetic hands, wrists, and elbows with unprecedented intuitiveness. Coapt's technology is compatible with virtually all major prosthetic arm and hand components on the market.
AI for Prosthetic Control & Machine Learning
Coapt leverages advanced machine learning algorithms to personalize and adapt prosthetic control to each user's unique muscle signal patterns. The Gen2 system includes an AI-enabled 'Control Coach' companion that analyzes user data and provides guidance for optimizing control.
Rehabilitation
Coapt's technology aims to enhance functional capabilities and independence for individuals with upper limb loss or difference. They are also actively involved in research and development of virtual reality (VR) based rehabilitation systems to improve prosthesis control and user experience.
Phantom Limb Pain Therapy
Coapt is developing a virtual reality (VR) rehabilitation system, the 'Coapt Phantom Limb Pain Management System,' designed to treat phantom limb pain (PLP) for both upper and lower extremity limb absence. This system uses EMG signals from residual limb muscles to control virtual environments for therapy.
Physician Tip

For physicians, Coapt's technology offers several key advantages. The **intuitive and natural control** provided by their pattern recognition system can significantly improve patient acceptance and daily function, reducing the mental effort required compared to traditional myoelectric controls. The **broad compatibility** of the Complete Control system with existing prosthetic components means it can be integrated into a wide range of patient setups, including those with Targeted Muscle Reinnervation (TMR) or Osseointegration. The **AI-enabled Control Coach** and on-the-go calibration empower patients to optimize their prosthetic control independently, potentially leading to fewer follow-up appointments for minor adjustments. Coapt also provides **reimbursement guidance and specialists** to assist clinicians through the process, and their products hold **FDA Class II Clearance**, offering a level of regulatory assurance.

Coapt's Complete Control Gen2 system is designed as an add-on controller kit that is compatible with virtually every prosthetic arm and hand component on the market today, including those from various manufacturers. It connects with mobile applications (iOS and Android 'Control Companion') for user personalization and the 'Control Coach' AI. Coapt also collaborates on research for VR-based rehabilitation systems, indicating potential future integrations with virtual reality platforms for therapy and pain management.

Products by Coapt

2 products in the directory

COMPLETE CONTROL System Gen2
Coapt
Neurology AI
Coapt's COMPLETE CONTROL System Gen2 uses AI and machine learning for intuitive, natural control of upper-limb prosthetics, enhancing functionality for individuals with limb loss or difference.
Alpha Control Liner System (ACLS)
Coapt
Neurology AI
The Alpha Control Liner System (ACLS) by Coapt is an FDA-cleared prosthetic interface solution with integrated electrodes, enhancing control, comfort, and ease of use for upper extremity prosthesis wearers by providing consistent myoelectric signal capture for advanced pattern recognition systems.

What the Web Says

Coapt appears to be two distinct companies: a medical device company specializing in myoelectric pattern recognition systems for upper limb prostheses, and a property letting agency based in Brighton, UK. The medical device company receives overwhelmingly positive reviews for its innovative technology that provides intuitive control for prosthetic users. The letting agency, however, has a mixed to negative reputation, with many complaints about poor communication, slow issue resolution, and deposit disputes, though some recent reviews are positive. There is no information available on G2, Glassdoor, or Capterra for the medical device company, and limited information for the letting agency on these platforms.

Overall: Mixed

Strengths

  • Intuitive and natural control for prosthetic users (medical device company)
  • Improved functionality and quality of life for amputees (medical device company)
  • AI-enabled Control Coach for automated feedback and instruction (medical device company)
  • Quick and easy calibration process for prosthetics (medical device company)
  • Supportive and knowledgeable team (letting agency - employer reviews)
  • Good communication and rapid response to issues (some letting agency reviews)

Limitations

  • Poor communication and slow response times (letting agency)
  • Issues with deposit returns (letting agency)
  • Unprofessional and unhelpful staff (letting agency)
  • Dirty properties upon move-in (letting agency)
  • Rebranded due to bad reputation (letting agency, formerly MTM Property Services)
  • Limited growth opportunities and poor management (some employer reviews for a company named Copart, which may be a different entity)

Based on reviews from: Indeed.com, Reddit, WinPO | Blog, YouTube, The Robot Report, Trustpilot, WhichPad - Student Reviews on Letting Agents, Comparably

Last updated: 2026-07-17

Videos

News, demos, and interviews about Coapt.

Loading videos...

Videos load interactively. If none appear, search YouTube for Coapt →

View all on YouTube

Press & Coverage

Coapt Myo Pattern Recognition
Coapt Secures New CMS Code for Upper-Limb Pattern Recognition Prostheses
Coapt has secured a new CMS code (L6700) for its Gen2 pattern recognition technology, establishing a recognized pathway to coverage for more intuitive prosthetic control for users.
unknown
Coapt Myo Pattern Recognition
Department of Defense Awards Tech Firm Coapt $2.3M to Develop Virtual Reality-based Therapy to Ease Phantom Limb Pain
Coapt received a $2.3 million grant from the Department of Defense to develop virtual reality and hardware-based therapies for phantom limb pain, building on their previous VR-based rehabilitation system.
2020-10
Coapt Myo Pattern Recognition
Coapt Acquires Liberating Technologies, Inc. from College Park Industries
Coapt acquired Liberating Technologies, Inc. (LTI) to enhance its research and development capabilities and accelerate the creation of advanced orthotics and prosthetics technologies.
2021-07
PR Newswire
Coapt Now First and Only Advanced Myoelectric Control System with FDA Class II Clearance
Coapt announced it obtained FDA Class II medical device clearance for its COMPLETE CONTROL System, making it the first and only myoelectric pattern recognition system to be cleared for marketing in the United States by the FDA.
2017-05
Shirley Ryan AbilityLab
$8.7 Million NIH Grant for First-of-its-Kind Bionic Arm Osseointegration Study
Shirley Ryan AbilityLab, with research partners, received an $8.7 million NIH grant to advance bionics through a novel osseointegration study for bionic arms, including an in-home trial of the e-OPRA system with Coapt Gen2 control.
2023-06
Cardiovascular Business
COAPT: Transcatheter Mitral Valve Repair Reduced Hospitalizations, Death in Heart Failure
Five-year follow-up data from the COAPT trial demonstrated that transcatheter edge-to-edge repair (TEER) with the MitraClip device significantly reduced hospitalizations and death in heart failure patients with severe secondary mitral regurgitation.
2023-03
European Heart Journal
Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial
A review of the COAPT trial's 5-year follow-up data highlights the sustained benefits of transcatheter mitral edge-to-edge repair (M-TEER) with MitraClip in reducing heart failure hospitalizations and mortality for patients with secondary mitral regurgitation.
2023-06
PubMed (Journal of the American College of Cardiology)
Transcatheter Edge-to-Edge Repair in 5000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study
The COAPT Post-Approval Study (COAPT-PAS), a large real-world study of 5,000 patients, reinforced the safety and effectiveness of the MitraClip System in patients with secondary mitral regurgitation.
2023-09

Frequently Asked Questions

Coapt's Complete Control Gen2 system employs advanced myoelectric pattern recognition powered by machine learning and artificial intelligence to decode a user's natural muscle signal patterns. This technology provides intuitive, multi-movement control of upper-limb prostheses, making prosthetic use more fluid and personalized, thereby improving functional independence and reducing cognitive burden for patients.
Coapt offers the Coapt Phantom Limb Pain Management System, a virtual reality (VR) therapy system designed for both in-clinic and at-home use. This non-invasive system uses electrode cuff technology and visual feedback to engage users in muscle contractions, aiming to retrain the brain's perception of the missing limb and reduce phantom limb pain. Clinical trials are underway to evaluate its effectiveness in improving pain and quality of life.
Coapt's Complete Control system was the first myoelectric pattern recognition system to achieve Class II FDA Clearance. The Gen2 system is designed to be compatible with virtually every major powered prosthetic arm and hand component on the market, offering clinicians flexibility in choosing components that best meet patient needs.
Coapt offers comprehensive support including dedicated sales, technical, clinical, and reimbursement specialists to guide clinicians through the process. They also provide clinician resources, a compatibility tool, and a mobile app (Control Companion with AI-enabled Control Coach) to assist users with personalization and function, aiming to reduce the need for frequent clinic visits.
While specific pricing is not publicly disclosed, Coapt is committed to assisting clinicians with the reimbursement process. They provide guidance, resources, and access to reimbursement specialists to help navigate insurance policies, compile necessary documentation, and facilitate claims for coverage of their pattern recognition platform.
Founded in 2012, Coapt emerged from research at the Shirley Ryan AbilityLab and was the first to introduce commercially available myoelectric pattern recognition technology for prosthetic control. Their continuous development, including the Gen2 system and PLP management system, along with ongoing research studies, indicates a commitment to innovation and strong relationships within the academic and clinical communities.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.